Cite

HARVARD Citation

    Ueno, M. et al. (n.d.). 625PDPembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study. Annals of oncology. p. . [Online]. 
  
Back to record